News Conference News ISC 2022 Tenecteplase Feasible Up to 24 Hours After Stroke Todd Neale February 15, 2022
News Daily News Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension Caitlin E. Cox February 11, 2022
News Daily News Homozygous FH Diagnosis Often Comes Late, With Lackluster Care Michael O'Riordan February 10, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer L.A. McKeown February 10, 2022
News Conference News ISC 2022 Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT Todd Neale February 09, 2022
News Conference News THT 2022 Probe Beyond Ejection Fraction to Understand and Manage HFpEF L.A. McKeown February 07, 2022
News Opinion Off Script Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation Charles C. Hong, MD, PhD February 04, 2022
Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022
News Daily News SCAI SHOCK: Update Refines Cardiogenic Shock Classification Caitlin E. Cox January 31, 2022
News Daily News ‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan Michael O'Riordan January 28, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Daily News DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis L.A. McKeown January 20, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022